Bristol-Myers Squibb patents receptor-interacting serine/threonine-protein kinase 1 inhibitors Aug. 31, 2018
Positive topline data presented from phase Ib study of TAR-302 in idiopathic overactive bladder Aug. 29, 2018
Elevated FGF23, a causative factor in the development of renal anemia and iron deficiency Aug. 20, 2018
RSS